SEC Form 4 · accession 0001125345-18-000012
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Eric Blasius Risser
Officer — Sr VP & Chief Business Officer
Period of report
Jan 24, 2018
Accepted (ET)
Jan 25, 2018 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 24, 2018 | M | 3,000 | $0.94 | A | 12,100 | D | |
| Common StockF1,F2 | Jan 24, 2018 | S | 3,000 | $22.50 | D | 9,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) | $0.94 | Jan 24, 2018 | M | 3,000 | D | Sep 24, 2009 | Mar 23, 2019 | Common Stock | 3,000 | 26,497 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted 11/14/17.
- F2This transaction was executed in multiple trades at prices ranging from $20.50 to $20.51.